NSC |
Compound |
Enrichment |
Correlation |
NSC 113908 |
Null |
0.01456670152525 |
0.5474982 |
NSC 225112 |
2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- |
0.01456670152525 |
0.58578933 |
NSC 266047 |
1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) |
0.01456670152525 |
0.33601008 |
NSC 3082 |
s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) |
0.01456670152525 |
0.54017189 |
NSC 30863 |
Null |
0.01456670152525 |
0.42735881 |
NSC 698955 |
Null |
0.0149342570376736 |
-0.078164498 |
NSC 710552 |
Null |
0.0149342570376736 |
0.32073355 |
NSC 754664 |
3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide |
0.0149342570376736 |
0.31387478 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0162638908166157 |
0.54806658 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0162638908166157 |
0.29284997 |